Marker Therapeutics logo
Marker Therapeutics MRKR
€ 1.22 -1.36%

Geschäftsbericht 2025
hinzugefügt 18.03.2026

report update icon

Marker Therapeutics Langfristiger Schuldenstrom 2011-2026 | MRKR

Langfristiger Schuldenstrom Jährlich Marker Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 577 K 620 K 389 K 204 K - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
620 K 204 K 448 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
FSD Pharma FSD Pharma
HUGE
103 K - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Athira Pharma Athira Pharma
ATHA
465 K - - $ 269 M usaUSA
Exelixis Exelixis
EXEL
27.9 M $ 46.83 -3.85 % $ 12.7 B usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 93.78 -1.55 % $ 27.2 B germanyGermany
Fortress Biotech Fortress Biotech
FBIO
2.13 M $ 2.48 -2.94 % $ 69.2 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.17 3.19 % $ 3.67 B usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 3.14 -0.32 % $ 653 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.66 9.25 % $ 6.03 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Genmab A/S Genmab A/S
GMAB
26 M $ 27.74 -0.54 % $ 17.1 B danmarkDanmark
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 22.41 -7.3 % $ 2.85 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
18.6 M $ 53.95 -2.05 % $ 4.85 B schweizSchweiz
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.63 -4.41 % $ 434 M britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael